Skip to main content
PLOS One logoLink to PLOS One
. 2026 Aug 11;21(8):e0355544. doi: 10.1371/journal.pone.0355544

Factors associated with fear and coping strategies during pandemic in female university students: The moderator role of physical activity and infection status

Emre Karaduman 1, Nazlıcan Toprak 1, Adem Çevik 1, Serhat Erail 1, Muhammet Hakan Mayda 2, Aydan Ermiş 1,*, Kürşat Acar 3, Kenan Şebin 4, Menderes Kabadayı 1, Ali Kerim Yılmaz 1, Ayşe Anderiman 1, Eda Karaduman 1, Özgür Bostancı 1
Editor: Wanli Zang5
PMCID: PMC13460565  PMID: 42579665

Abstract

The COVID-19 pandemic has generated widespread psychological distress worldwide, with fear emerging as a central emotional response; however, its role in shaping coping processes, particularly among female university students, remains unclear. The present study investigates the relationship between fear of COVID-19 and coping strategies in female university students, with a specific focus on the moderating role of various variables. Participants were 1000 female university students aged 21.5 (2.5) years, who completed a self-report questionnaire about levels of fear regarding COVID-19 and the coping strategies employed during the post-emergency phase. The result showed that fear of COVID-19 (FCV-19S) was positively related to coping with the outbreak (COS). Physical activity status and COVID-19 positive or negative experiences moderated the relationship between FCV-19S and COS. These findings suggest that individual characteristics such as sedentary lifestyle habits and firsthand infection experiences, may continue to shape COVID-19-related fear and coping responses even after the acute emergency phase has subsided. An intervention such as regular exercise that aims to develop and improve coping dynamics among people in response to new challenges posed by stressful events or public health crises, like COVID-19 infection, seems warranted.

Introduction

The COVID-19 pandemic has caused unprecedented global health concerns, not only affecting individuals’ physical health but also often directly their mental health [1–3], with several variants still continuing to pose threats. Among these concerns, a sense of fear, especially fear of COVID-19, emerged as a prevailing and dominant experience for young college students [4]. The virus’s high potential for contagion, serious health problems, and lethal nature have instilled a fear in individuals, making them feel that both themselves and their loved ones are at risk [1,5,6].

Fear, as a primal emotion, triggers various psychological and physiological reactions that can result in maladaptive behaviors or elevated stress responses detrimental to one’s health [7,8]. Previous studies have shown that fear in the pandemic context can lead to serious stress related mental consequences [9–11]. A systematic review of 398,771 participants reported the prevalence of psychological problems such as depression, anxiety, and distress during the COVID-19 pandemic were 28%, 27%, and 50%, respectively [12], while a meta-analysis of 221,970 participants found the pooled prevalence rates for these disorders were 31%, 32%, and 41%, noting a marked rise since the pandemic’s onset [13]. Given the numerous psychological challenges that COVID-19 presents, it is crucial to comprehend the factors linked to fear and the subsequent coping strategies adopted by individuals.

Coping strategies, which are typically accepted as cognitive and behavioral efforts to manage specific internal and external demands [14], have emerged as one of the most important tools people have used to reduce the psychological and physiological harms associated with the threat of infection during the pandemic [15]. Considering the symbiotic relationship between fear and coping, it can be inferred that the magnitude of fear resulting from individual differences might dictate the selection and efficacy of coping strategies, and inversely, the efficacy of a coping strategy can modulate the levels of fear [14]. Therefore, the theoretical framework of the study was constructed based on the Stress and Coping Process Model proposed by Lazarus and Folkman [14]. This model suggests that individuals’ responses to stress are shaped by their cognitive appraisal of the stressor (e.g., fear of COVID-19) and the coping resources they can utilize. Fear of COVID-19, conceptualized as a perceived environmental threat, can trigger coping strategies at varying levels depending on personal characteristics (e.g., individual experiences) [9].

Previous studies have reported that young female students may be susceptible to mental health issues [16,17] and the development of different coping strategies [18]. Thus, it is essential to note that fear and coping strategies may vary across different populations. In particular, it is stated that the interactions between biological factors, social determinants, gender stereotypes, gender roles, social stigma, inequality, and social autonomy contribute to women experiencing more stress, anxiety, and depression than men [19–21]. This gender factor emerges as an important determinant in both the experience of fear and the development of coping strategies during or post-pandemic. Previous studies have suggested that both adult and college-aged women are affected by the adverse psychological impacts of the pandemic due to increased fear [4,6,22,23]. Despite the growing body of research examining the psychological consequences of the COVID-19 pandemic, the factors that may influence the relationship between fear of COVID-19 and coping strategies remain insufficiently understood, particularly among female university students. Existing studies have primarily focused on the independent effects of fear or coping outcomes, whereas evidence regarding individual characteristics that may modify this relationship is limited. Therefore, the present study contributes to the literature by exploring the potential moderating roles of physical activity status and COVID-19 infection experience in a large sample of female university students, providing a more comprehensive understanding of factors associated with adaptive responses during public health crises.

Therefore, the main objective of this study was to investigate the moderating effect of various variables on the relationship between fear of COVID-19 and coping strategies utilized by female university students during the post-emergency phase. First, we hypothesized that there is a significant relationship between COVID-19 fear and coping strategies in female university students (H1). Second, we hypothesized that various factors may have moderating effects of COVID-19 fear on strategies to cope with the outbreak (H2). Based on previous research, a research model was developed to test the following hypothesis (Fig 1).

Fig 1. Conceptual diagram testing the moderation of variables between FCV-19S and COS.

Fig 1

Materials and methods

Participants and procedure

The sample includes students from various faculties at the University of Ondokuz Mayıs in Türkiye, including Dentistry, Divinity, Education, Health Sciences, and Medicine. This study employed a convenience sampling approach to recruit 1000 female university students. This method was chosen due to its practicality in accessing participants within the researchers’ professional networks, as well as the significant restrictions commonly encountered in scientific research conducted during the post-emergency phase. Among participants classified as COVID-19 positive, infection status was based on self-reported laboratory-confirmed diagnoses recorded in the official Turkish Ministry of Health electronic health record system (e-Nabız), which is directly accessible to individuals. Furthermore, all participants with a COVID-19 infection reported having received vaccination prior to infection. The recreationally active group comprised individuals who declared dedicating more than six hours per week to activities such as running, cycling, swimming, tennis, or fitness. On the other hand, the sedentary group consisted of females who did not regularly practice any sports activities or did less than two hours of exercise per week.

A cross-sectional research design was employed in which two standardized scales were used, and their associations with various variables were examined. In this study, the fear was assessed by the Fear of COVID-19 scale (FCV-19S) [11], and coping strategies were evaluated by the Coping with Outbreak Scale (COS) [24]. Participants were required to: a) be at least 18 years of age, b) have no mental or neurological disorders, c) be female university students, and d) consent to participate. Eligibility criteria have been kept to a minimum to ensure the inclusion of the target individual. However, the study excluded 119 students who still did not meet the conditions above and did not fully respond to all of the survey questions. The data of the study were collected via face-to-face administration of a questionnaire from willing volunteers between July-December 2023. The personal information form and scales took to complete 7−10 minutes. The name and other personal information of the study participants were protected. This study was conducted in accordance with the Declaration of Helsinki and was approved by the Social and Human Sciences Ethics Committee at the University of Ondokuz Mayıs (approval number: 12901−562). All participants provided written informed consent.

Measures

The personal information form.

This form was used to collect data on the participants’ socio-demographic information, including age, faculty, physical activity, and COVID-19 positive and negative status (oneself or close circles). Additional information was also collected regarding participants’ COVID-19 vaccination status and number of vaccine doses received. Furthermore, the collected data includes various aspects such as the severity of the disease in those who have had COVID-19, confirmed infection, or death (from COVID-19 infection) information in relatives or close friends. In the present study, the FCV-19S and COS were used to evaluate participants’ current COVID-19-related responses during the post-emergency phase.

Fear of COVID-19 Scale (FCV-19S).

This scale was developed by Ahorsu et al. [11] and subsequently adapted to Turkish by Satici et al. [25]. The scale consists of a unidimensional, seven item, and five-point Likert-type scoring system (strongly disagree = 1 to strongly agree = 5). Factor loadings of the original scale range from .66 to .74, and corrected item-total correlations vary between .47 and .56. The internal consistency (α = .82) and the scale’s test-retest reliability (ICC = .72) were acceptable. Furthermore, the FCV-19S was positively correlated with perceived vulnerability, hospital anxiety, and depression [11]. In the present study, Cronbach’s α for the scale was .85. There is no reverse item on the scale. The total score of the fear of COVID-19 scale, obtained by summing the individual response items, ranges from 7 to 35, with higher scores indicating greater fear of COVID-19.

Coping with the outbreak scale (COS).

The Coping with Outbreak Scale (COS) was developed by Hatun et al. to reveal coping strategies during the COVID-19 outbreak [24]. The scale includes a four-teen item and structurally six-point Likert-type scoring system (I have never done it = 0 to I have done it very often = 5). The scale includes four dimensions: cognitive, transcendental, behavioral, and relational coping. In participants’ coping strategies during the post-emergency phase, the cognitive dimension involves accessing accurate information and self-suggestion, the transcendental dimension entails resorting to hopeful and spiritual means, the behavioral dimension includes acquiring various occupations, and the relational dimension involves seeking social support. The factor loading of the original scale was .84, and the corrected item-total correlations ranged between .39 and .71. The reliability coefficients for each sub-dimension are as follows: cognitive coping (.77), transcendental coping (.70), behavioral coping (.76), and relational coping (.79) [24]. In the present study, the Cronbach’s alpha coefficient was .88 for the total scale and .79, .78, .78, and .83 for the cognitive, transcendental, behavioral, and relational coping strategies, respectively. There is no reverse item on the scale. A high score on the scale indicates that the person has a high coping ability against the pandemic.

Data analysis

Data analyses were conducted using IBM SPSS Statistics version 25.0 (IBM Inc., Armonk, NY, USA). Descriptive data were presented as mean, standard deviations (SD) and frequencies (%). Normality assumption was evaluated by visual inspection of the histograms (approximating a normal distribution) and applying a Kolmogorov–Smirnov test. The relationships between the FCV-19S and the COS were evaluated with Spearman’s rho (ρ). A correlation of ≥0.10 was considered as small, ≥ 0.30 as moderate, and ≥0.50 as large in terms of effect size. The moderation analysis was conducted using Model 1 of the PROCESS Macro (version 4.3) integrated with SPSS [26] to test the moderating effects of variables (M) between the FCV-19S (X) and the COS (Y) (Fig 1). The statistical significance of the moderation was set at 95% confidence intervals (CI) with the recommended 5000 bootstrap samples [27]. An interaction effect was supported by a significant R2 change (ΔR2). Aguinis suggests that interaction effects are expected to explain an additional range of 1% to 3% in unique variability related to the criterion [28]. We also reported unstandardized coefficients (B) for moderation analyses. Graphical tools were utilized to show the slope of the moderation outcomes (Fig 3). Furthermore, we used Harmon’s one-factor test to assess common method bias. If the percentage variance extracted of the single factor over 50%, the common method biases issue was detected. The Harman’s single-factor results demonstrated the single factor value at 28.4% of the total variance. This guaranteed the common method bias did not appear in this study. Graphical representations were generated using GraphPad Prism (Version 10; GraphPad Software, San Diego, CA, USA, http://www.graphpad.com/).

Fig 3. Moderating effect of physical activity and COVID-19 status in relation to FCV-19S and COS (slope plots).

Fig 3

COS = Coping with Outbreak Scale; FCV-19S = Fear of COVID-19 Scale.

Results

The descriptive characteristics of participants are summarized in Table 1. The findings of the study revealed a positive correlation between the total scores of the FCV-19S and COS (ρ = 0.451, p < 0.001). Furthermore, FCV-19S exhibited significant correlations with sub-dimensions, which cognitive (ρ = 0.259), transcendental (ρ = 0.320), behavioral (ρ = 0.239), and relational coping (ρ = 0.237) (p < 0.001 for all) (Fig 2).

Table 1. Descriptive characteristics of participants.

N Mean (SD) or %
Characteristics
Age, years 1000 21.5 (2.5)
Physical activity status
Recreationally active individual 247 24.7
Sedentary 753 75.3
COVID-19 status of participants
COVID-19 positive 274 27.4
COVID-19 negative 726 72.6
COVID-19 status of relatives
COVID-19 positive 490 49
COVID-19 negative 510 51
COVID-19 status of close friends
COVID-19 positive 764 76.4
COVID-19 negative 236 23.6
Relatives or close friends who died from COVID-19
Yes 536 53.6
No 464 46.4
Emotional response to meeting with a post-COVID survivor
I get worried 314 31.4
I am comfortable 686 68.6
COVID-19 vaccination status
Vaccinated 988 98.8
Unvaccinated 12 1.2
Number of vaccine doses
Dose 1 26 2.6
Dose 2 962 96.2
Disease severity in COVID-19 patients
Mildly 97 9.7
Moderate 134 13.4
Severe 43 4.3
Measurements
FCV-19S 18.9 (7.0)
COS (Total score) 36.6 (9.7)
COS – Cognitive 7.6 (3.7)
COS – Transcendental 11.0 (4.9)
COS – Behavioral 8.4 (3.6)
COS – Relational 9.6 (5.0)

SD = Standard deviation; COS = Coping with Outbreak Scale; FCV-19S = Fear of COVID-19 Scale

Fig 2. Scatterplots with regression lines and correlation coefficients between FCV-19S and COS.

Fig 2

COS = Coping with Outbreak Scale; FCV-19S = Fear of COVID-19 Scale; ** p < 0.001. Data are presented as correlation coefficients (ρ).

To test hypothesis 2, we interrogated the potential moderating roles of all descriptive characteristics in the relationship between the fear of COVID-19 and related coping strategies. Table 2 shows that physical activity and COVID-19 status had a moderating effect on participants’ coping strategies used in response to COVID-19 fear (p < 0.050). The results indicated that the physical activity status significantly moderated the relationship between the FCV-19S and COS (B = −6.97, p < 0.001). Accordingly, the simple slope analysis revealed a significant difference in the effect between sedentary (simple slope = 0.79, t = 17.877, p < 0.050) and recreationally active individuals (simple slope = 0.28, t = 3.79, p < 0.001), highlighting the varying impact of physical activity status on the COVID-19 fear and the coping strategies (Fig 3). Moreover, the PROCESS Macro analysis revealed a significant interaction effect between the fear of COVID-19 and physical activity status (FCV-19 x MV1) on the coping strategies employed with a regression coefficient of B = 0.51, indicating statistical significance (p < 0.001). The MV1 predictor in the model explained 26% of the variance in the COS variable (Table 2).

Table 2. Moderating effects of physical activity and COVID-19 status on the relationship between FCV-19S and COS.

Variable entered COS
B SE t 95% CI
FCV-19S −0.23 0.15 −1.49 [-0.53 to 0.07]
Physical activity status (MV1) −6.97 1.70** −4.10 [-10.31 to -3.64]
FCV-19S x MV1 0.51 0.09** 5.91 [0.34 to 0.68]
MV1 – Model summary R2  =  0.26, ΔR2 = 0.025, F = 34.984
FCV-19S 1.31 0.14 9.29 [1.04 to 1.59]
COVID-19 status (oneself) (MV2) 4.98 1.66* 3.00 [1.72 to 8.24]
FCV-19S x MV2 −0.39 0.08** −4.77 [-0.55 to -0.23]
MV2 – Model summary R2  =  0.26, ΔR2 = 0.017, F = 22.780

B = Unstandardized regression coefficients; COS = Coping with Outbreak Scale; F  =  F-test; SE =  standard error; t  =  t-test score; 95% CI = confidence interval; MV: Moderate variable; *p  < 0.050; **p  < 0.001

Our study findings also showed that participants’ COVID-19 status had a moderating effect on the relationship between fear and coping strategies (B = 4.98, p < 0.050). The simple slope analysis indicated a significant difference in the impact between COVID-19 positive (simple slope = 0.92, t = 13.856, p < 0.001) and negative individuals (simple slope = 0.53, t = 11.583, p < 0.001) (Fig 3). Additionally, the interaction effect between fear of COVID-19 and COVID-19 status (FCV-19 x MV2) had a significant influence on coping strategies (B = −0.39, p < 0.001). The MV2 predictor in the model accounted for 26% of the variance in the COS variable (Table 2).

Discussion

The primary aim of this study was to investigate the relationship between fear of COVID-19 and coping strategies among female university students and to determine whether selected individual characteristics moderated this relationship. This study provides novel findings demonstrating the relationship between fear of COVID-19 and related coping strategies in female university students, and highlighting the factors moderating this relationship. Our results indicated a positive association between fear of COVID-19 and coping strategies, which is in alignment with the first hypothesis. Furthermore, the study reveals significant associations between fear of COVID-19 and sub-dimensions of coping, including cognitive, transcendental, behavioral and relational coping. These results suggest that individuals may develop both more and various coping strategies as fear levels increase.

The intricate relationship between fear of COVID-19 and coping strategies can be interpreted by the broader paradigm of stress and coping theory proposed by Lazarus and Folkman [14]. Stress is perceived as a relationship between the person and their environment and is viewed by the person as taxing or exceeding his/her resources and putting his/her well-being at risk. Coping encompasses the dynamic cognitive and behavioral efforts used to manage specific external and/or internal demands [14]. Numerous studies have indicated that the lethal danger posed by COVID-19 to human health has caused fear, a potential environmental stressor among people [5,6]. This stressor, known as the fear of COVID-19, quickly became a significant psychological concern that profoundly affects people’s mental health leading to issues like depression, anxiety, and stress [10,29,30]. Furthermore, a recent study supported a notable prevalence of fear-related mood states, including emotional disturbance, irritability, and anger, among individuals in the post-pandemic phase [31]. As an emotion, fear can trigger a variety of psychological responses and coping strategies to deal with dangerous or threatening situations, activating the instinctive and physical behaviors of the individual [11,29]. Our findings suggest a positive correlation between the fear of COVID-19 and coping strategies among female university students during the post-emergency phase. Perceiving COVID-19 infection as a major threat in our female cohort might have induced a fear response, prompting them to develop more effective coping strategies. We also reported that the transcendence sub-dimension was favoured as the most used coping strategies in the relationship between COVID-19 and pandemic coping strategies in this cohort.

The findings regarding the moderating roles of physical activity status and previous COVID-19 infection experience emphasize the importance of individual differences in coping with the COVID-19-related concerns. Our findings were also in line with the second hypothesis, we observed that physical activity status plays a moderating role in the relationship between fear of COVID-19 and coping with the outbreak. In particular, the moderating effect of individuals’ physical activity status on fear of COVID-19 and coping levels is more pronounced in sedentary individuals (vs. recreationally active individuals). Previous studies have reported that regular exercise positively supports individuals’ mental health components such as psychological resilience, well-being, stress management and self-efficacy perceptions [32–34]. However, regular physical activity has also been demonstrated to considerably reduce depression and anxiety levels and to have improving effects on post-traumatic symptoms [35–37]. Senışık and colleagues [37] stated that athletes survived the pandemic with less mental strain compared to sedentary individuals and that regular exercise habits play an important role in reducing psychological distress during challenging times [38]. Likewise, several studies have shown that regular physical activity before or during the COVID-19 pandemic is associated with better mental health outcomes such as psychological flexibility and well-being in young people [39–41]. A few studies suggest that psychological flexibility and psychological well-being related to adaptive coping may play a moderate role in this relationship [42–44]. Psychological flexibility refers to an individual’s ability to adapt and respond effectively to challenging or stressful situations [44], which may be an important factor in understanding and predicting how individuals overcome the challenges posed by the COVID-19-related concerns. The steeper positive slope observed among sedentary individuals suggests that their coping responses were more strongly contingent on increasing fear of COVID-19. More specifically, sedentary individuals may have been more likely to activate coping strategies when fear became more salient. By contrast, the flatter but still significant slope among recreationally active individuals may indicate that their coping responses were less dependent on elevated fear levels. This pattern may reflect a more stable baseline repertoire of adaptive coping resources among active individuals, potentially supported by the beneficial effects of regular physical activity on psychological resilience, well-being, stress regulation, and self-efficacy. Therefore, physical activity may not simply reduce fear or coping needs; rather, it may alter the extent to which coping responses are driven by fear. However, it is also important to emphasize that multiple factors, including personal experiences, individual differences, and pre-existing health conditions may also contribute to this relationship. Nevertheless, further research is needed to identify factors that moderate the relationship between fear of COVID-19 and related coping responses.

On the other hand, we reported that individuals’ COVID-19 status (positive or negative) may have a moderating role in the relationship between fear of COVID-19 and coping levels with the pandemic. In particular, the moderate effect of individuals’ infection status on COVID-19 fear and coping levels is more pronounced in positive individuals (vs. negatives). Positive cases may experience high fear and anxiety due to their direct experience with the virus, which can lead to stress, anxiety and affect their general well-being. Several studies have reported more severe symptoms of stress, anxiety and depression in people who reported a positive COVID-19 test, including those who did not require hospitalisation [45,46]. Likewise, Ewid et al. found that stress, anxiety, and depression levels were significantly higher in students who had close contact with COVID-19 cases and whose lives were affected by COVID-19 compared to their peers [47]. Our findings align with the notion that an individual’s infection status can profoundly impact their psychological state and, consequently, their coping strategies. People who directly experience the physical and psychological damages of the virus may be more inclined to utilise active coping strategies. González-Castro et al. argued that an individual’s perceived vulnerability to a disease, combined with their perception of the disease’s severity, can influence their motivation to adopt health protective behaviors [48]. Thus, COVID-19 positive individuals might perceive the disease as more severe and sensitive than those who are negative, which may elevate their level of fear, causing them to develop various or more coping strategies. In addition, Koçak et al. noted that having PCR-positive friends or family had a moderate effect on fear of COVID-19, which causes depression, anxiety, and stress in people [30]. This suggests that the stigma associated with a positive diagnosis may increase fear and shape coping behaviors even among those who test negative. Nevertheless, it should also be acknowledged that more than half of the participants reported the loss of a relative or close friend due to COVID-19. Such bereavement-related experiences may have influenced fear perceptions and coping responses independently of participants’ own infection history and therefore represent a potential source of unmeasured psychological variability.

Strength and limitations

One strength of our study is its addition to the literature on COVID-19 related fear and coping, with a specific focus on a young, exclusively female demographic. This research further reinforces the limited literature that investigates both direct and indirect influences in identifying key modulating factors between fear and coping strategies during the post-emergency phase. Nevertheless, the findings of this study should be considered in light of some limitations. Most importantly, a cross-sectional design was used for this study, thus causal interpretations about the relationships between variables are quite limited. Another potential limitation was the use of self-report measures. Participants might have under-or-over-reported their experiences which are potentially susceptible to scientifically desirable outcomes. To enhance the reliability of self-report responses, participants were assured of their anonymity and confidentiality, aiming to increase the honesty and objectivity of their feedback. Finally, the use of convenience sampling limits the extent to which these findings can be generalized beyond the specific cohort of female university students who participated in the study. However, future studies using randomized or stratified sampling methods could be valuable in determining whether these results are potentially applicable to other populations.

Future directions

The findings of this study provide important insights for the management of future public health crises, particularly in light of the experiences gained from the COVID-19 pandemic. It emphasizes the critical importance of robust surveillance systems and early intervention strategies to mitigate the long- or short-term psychological effects that may arise from the infection disproportionately affecting potentially susceptible groups [49,50]. The results contribute to a better understanding of the factors influencing coping strategies during global health crises, particularly when systemic weaknesses—such as inequalities in access to healthcare and vaccine distribution—become apparent. In the future, incorporating key factors that influence coping strategies—such as physical activity—into global health preparedness plans could be critical for strengthening resilience against future pandemics.

Conclusion

In this study, we provided new insights into the relationship between fear of COVID-19 and coping strategies among female university students, highlighting the role of moderating factors in this relationship. Our results emphasize a positive correlation between fear of COVID-19 and COS strategies, suggesting that individuals may adopt diverse coping responses based on their level of fear. Furthermore, we reported the crucial role of physical activity status and COVID-19 positive or negative experiences as key moderators in relationship between the fear and coping during the post-emergency phase. These findings suggest that individual characteristics—like sedentary lifestyle habits and firsthand experiences with the infection—may intensify fear responses, thereby shaping coping strategies. Consequently, this model can guide professionals’ interventions to develop and improve coping dynamics among people in response to the new challenges posed by stressful events or public health crises such as COVID-19 infection in their psycho-social context.

Data Availability

De-identified participant-level data underlying the findings are provided as Supporting information (S1 Dataset; Excel format). Summary data are included in the manuscript. The dataset has been anonymized to protect participant privacy.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Autenrieth LK, Asselmann E, Melzig CA, Benke C. Fear of COVID-19 predicts increases in anxiety, depressive symptoms, health anxiety, psychosocial distress, and loneliness: findings from a prospective two-year follow-up study. J Psychiatr Res. 2024;177:162–8. doi: 10.1016/j.jpsychires.2024.07.018 [DOI] [PubMed] [Google Scholar]
  • 2.Tracy MF, Hagstrom S, Mathiason M, Wente S, Lindquist R. Emotional, mental health and physical symptom experience of patients hospitalized with COVID-19 up to 3 months post-hospitalization: a longitudinal study. J Clin Nurs. 2024;33(2):591–605. doi: 10.1111/jocn.16880 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Agha S. Mental well-being and association of the four factors coping structure model: a perspective of people living in lockdown during COVID-19. Ethics Med Public Health. 2021;16:100605. doi: 10.1016/j.jemep.2020.100605 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wang F, Zhang L, Ding L, Wang L, Deng Y. Fear of COVID-19 among college students: a systematic review and meta-analysis. Front Public Health. 2022;10:846894. doi: 10.3389/fpubh.2022.846894 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Yang Y, Wang H. Fear of COVID-19 and anxiety: serial mediation by trust in the government and hope. Psychol Res Behav Manag. 2023;16:963–70. doi: 10.2147/PRBM.S399466 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Enea V, Eisenbeck N, Petrescu TC, Carreno DF. Perceived impact of quarantine on loneliness, death obsession, and preoccupation with god: predictors of increased fear of COVID-19. Front Psychol. 2021;12:643977. doi: 10.3389/fpsyg.2021.643977 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fraunfelter L, Gerdes ABM, Alpers GW. Fear one, fear them all: a systematic review and meta-analysis of fear generalization in pathological anxiety. Neurosci Biobehav Rev. 2022;139:104707. doi: 10.1016/j.neubiorev.2022.104707 [DOI] [PubMed] [Google Scholar]
  • 8.Sloan MM, Haner M, Graham A, Cullen FT, Pickett JT, Jonson CL. Pandemic emotions: the extent, correlates, and mental health consequences of fear of COVID-19. Sociol Spect. 2021;41(5):369–86. doi: 10.1080/02732173.2021.1926380 [DOI] [Google Scholar]
  • 9.Huda N, Shaw MK, Chang HJ, Putri ST, Pranata S. The mediating role of coping styles in the relationship between fear of COVID-19 and mental health problems: a cross-sectional study among nurses. BMC Public Health. 2024;24(1):545. doi: 10.1186/s12889-024-17863-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Erbiçer ES, Metin A, Çetinkaya A, Şen S. The relationship between fear of COVID-19 and depression, anxiety, and stress. Eur Psychol. 2021;26(4):323–33. doi: 10.1027/1016-9040/a000464 [DOI] [Google Scholar]
  • 11.Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict. 2022;20:1537–45. doi: 10.1007/s11469-020-00270-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Nochaiwong S, Ruengorn C, Thavorn K, Hutton B, Awiphan R, Phosuya C, et al. Global prevalence of mental health issues among the general population during the coronavirus disease-2019 pandemic: a systematic review and meta-analysis. Sci Rep. 2021;11(1):10173. doi: 10.1038/s41598-021-89700-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wu T, Jia X, Shi H, Niu J, Yin X, Xie J, et al. Prevalence of mental health problems during the COVID-19 pandemic: a systematic review and meta-analysis. J Affect Disord. 2021;281:91–8. doi: 10.1016/j.jad.2020.11.117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lazarus RS, Folkman S. Stress, appraisal, and coping. New York: Springer Publishing Company; 1984. [Google Scholar]
  • 15.Achour M, Souici D, Bensaid B, Binti Ahmad Zaki N, Alnahari AAA. Coping with anxiety during the COVID-19 pandemic: a case study of academics in the muslim world. J Relig Health. 2021;60(6):4579–99. doi: 10.1007/s10943-021-01422-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Gao W, Ping S, Liu X. Gender differences in depression, anxiety, and stress among college students: a longitudinal study from China. J Affect Disord. 2020;263:292–300. doi: 10.1016/j.jad.2019.11.121 [DOI] [PubMed] [Google Scholar]
  • 17.Seedat S, Scott KM, Angermeyer MC, Berglund P, Bromet EJ, Brugha TS, et al. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry. 2009;66(7):785–95. doi: 10.1001/archgenpsychiatry.2009.36 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Meeks K, Peak AS, Dreihaus A. Depression, anxiety, and stress among students, faculty, and staff. J Am Coll Health. 2023;71(2):348–54. doi: 10.1080/07448481.2021.1891913 [DOI] [PubMed] [Google Scholar]
  • 19.Baños RM, Miragall M. Gender matters: a critical piece in mental health. Span J Psychol. 2024;27:e28. doi: 10.1017/SJP.2024.29 [DOI] [PubMed] [Google Scholar]
  • 20.Kirkbride JB, Anglin DM, Colman I, Dykxhoorn J, Jones PB, Patalay P, et al. The social determinants of mental health and disorder: evidence, prevention and recommendations. World Psychiatry. 2024;23(1):58–90. doi: 10.1002/wps.21160 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lathabhavan R. Covid-19 effects on psychological outcomes: how do gender responses differ?. Psychol Rep. 2023;126(1):117–32. doi: 10.1177/00332941211040428 [DOI] [PubMed] [Google Scholar]
  • 22.Maslakçı A, Sürücü L. Gender effects on depression, anxiety, and stress regarding the fear of COVID-19. Trends in Psychol. 2022;32(1):152–64. doi: 10.1007/s43076-022-00227-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Metin A, Erbiçer ES, Şen S, Çetinkaya A. Gender and COVID-19 related fear and anxiety: a meta-analysis. J Affect Disord. 2022;310:384–95. doi: 10.1016/j.jad.2022.05.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hatun O, Di̇cle AN, Demi̇rci̇ İ. Psychological reflections of the coronavirus pandemic and coping with pandemic. TurkishStudies. 2020;531–54. doi: 10.7827/turkishstudies.44364 [DOI] [Google Scholar]
  • 25.Satici B, Gocet-Tekin E, Deniz ME, Satici SA. Adaptation of the fear of COVID-19 scale: its association with psychological distress and life satisfaction in Turkey. Int J Ment Health Addict. 2021;19(6):1980–8. doi: 10.1007/s11469-020-00294-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hayes AF, Rockwood NJ. Conditional process analysis: concepts, computation, and advances in the modeling of the contingencies of mechanisms. Am Behav Sci. 2020;64(1):19–54. doi: 10.1177/0002764219859633 [DOI] [Google Scholar]
  • 27.Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. 3rd ed. New York: The Guilford Press; 2022. [Google Scholar]
  • 28.Aguinis H. Regression analysis for categorical moderators. New York: Guilford Press; 2004. [Google Scholar]
  • 29.Li R. Fear of COVID-19: what causes fear and how individuals cope with it. Health Commun. 2022;37(13):1563–72. doi: 10.1080/10410236.2021.1901423 [DOI] [PubMed] [Google Scholar]
  • 30.Koçak O, Koçak ÖE, Younis MZ. The psychological consequences of COVID-19 fear and the moderator effects of individuals’ underlying illness and witnessing infected friends and family. Int J Environ Res Public Health. 2021;18(4):1836. doi: 10.3390/ijerph18041836 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Jamshaid S, Bahadar N, Jamshed K, Rashid M, Imran Afzal M, Tian L, et al. Pre- and Post-Pandemic (COVID-19) mental health of international students: data from a longitudinal study. Psychol Res Behav Manag. 2023;16:431–46. doi: 10.2147/PRBM.S395035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kern ML, Armstrong P. Exercise, physical activity, and mental health. Encyclopedia of mental health. Elsevier; 2023. 849–56. doi: 10.1016/b978-0-323-91497-0.00237-x [DOI] [Google Scholar]
  • 33.Wu R, Jing L, Liu Y, Wang H, Yang J. Effects of physical activity on regulatory emotional self-efficacy, resilience, and emotional intelligence of nurses during the COVID-19 pandemic. Front Psychol. 2022;13:1059786. doi: 10.3389/fpsyg.2022.1059786 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Faulkner J, O’Brien WJ, McGrane B, Wadsworth D, Batten J, Askew CD, et al. Physical activity, mental health and well-being of adults during initial COVID-19 containment strategies: a multi-country cross-sectional analysis. J Sci Med Sport. 2021;24(4):320–6. doi: 10.1016/j.jsams.2020.11.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Wolf S, Seiffer B, Zeibig J-M, Welkerling J, Brokmeier L, Atrott B, et al. Is Physical activity associated with less depression and anxiety during the COVID-19 pandemic? A rapid systematic review. Sports Med. 2021;51(8):1771–83. doi: 10.1007/s40279-021-01468-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Schuch FB, Stubbs B, Meyer J, Heissel A, Zech P, Vancampfort D, et al. Physical activity protects from incident anxiety: a meta-analysis of prospective cohort studies. Depress Anxiety. 2019;36(9):846–58. doi: 10.1002/da.22915 [DOI] [PubMed] [Google Scholar]
  • 37.Schuch FB, Vancampfort D, Firth J, Rosenbaum S, Ward PB, Silva ES, et al. Physical activity and incident depression: a meta-analysis of prospective cohort studies. Am J Psychiatry. 2018;175(7):631–48. doi: 10.1176/appi.ajp.2018.17111194 [DOI] [PubMed] [Google Scholar]
  • 38.Şenışık S, Denerel N, Köyağasıoğlu O, Tunç S. The effect of isolation on athletes’ mental health during the COVID-19 pandemic. Phys Sportsmed. 2021;49(2):187–93. doi: 10.1080/00913847.2020.1807297 [DOI] [PubMed] [Google Scholar]
  • 39.LaForge-MacKenzie K, Tombeau Cost K, Tsujimoto KC, Crosbie J, Charach A, Anagnostou E, et al. Participating in extracurricular activities and school sports during the COVID-19 pandemic: associations with child and youth mental health. Front Sports Act Living. 2022;4:936041. doi: 10.3389/fspor.2022.936041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sokić J, Popov S, Dinić BM, Rastović J. Effects of physical activity and training routine on mental health during the COVID-19 pandemic and curfew. Front Psychol. 2021;12:624035. doi: 10.3389/fpsyg.2021.624035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Engels ES, Mutz M, Demetriou Y, Reimers AK. Levels of physical activity in four domains and affective wellbeing before and during the Covid-19 pandemic. Arch Public Health. 2021;79(1):122. doi: 10.1186/s13690-021-00651-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Arslan G, Allen K-A. Exploring the association between coronavirus stress, meaning in life, psychological flexibility, and subjective well-being . Psychol Health Med. 2022;27(4):803–14. doi: 10.1080/13548506.2021.1876892 [DOI] [PubMed] [Google Scholar]
  • 43.Tindle R, Hemi A, Moustafa AA. Social support, psychological flexibility and coping mediate the association between COVID-19 related stress exposure and psychological distress. Sci Rep. 2022;12(1):8688. doi: 10.1038/s41598-022-12262-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Dawson DL, Golijani-Moghaddam N. COVID-19: psychological flexibility, coping, mental health, and wellbeing in the UK during the pandemic. J Contextual Behav Sci. 2020;17:126–34. doi: 10.1016/j.jcbs.2020.07.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.da Graca B, Bennett MM, Powers MB, Gottlieb RL, Waddimba AC, Warren AM. Psychological differences in adults with and without a COVID-19 diagnosis. J Ment Health. 2022;31(4):560–7. doi: 10.1080/09638237.2021.2022617 [DOI] [PubMed] [Google Scholar]
  • 46.Nigatu YT, Elton-Marshall T, Wells S, Jankowicz D, Wickens CM, Hamilton HA. The association between COVID-19 diagnosis or having symptoms and anxiety among Canadians: a repeated cross-sectional study. Anxiety Stress Coping. 2021;34(5):503–12. doi: 10.1080/10615806.2021.1932837 [DOI] [PubMed] [Google Scholar]
  • 47.Ewid M, Amal Y, Billah SMB, Kalou Y, Zitoun OA, Alnaser AR, et al. Impact of the COVID-19 pandemic on the psychological status of undergraduate medical students in Saudi Arabia: a cross-sectional double-scale study. Medicine (Baltimore). 2023;102(14):e33487. doi: 10.1097/MD.0000000000033487 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.González-Castro JL, Ubillos-Landa S, Puente-Martínez A, Gracia-Leiva M. Perceived vulnerability and severity predict adherence to COVID-19 protection measures: the mediating role of instrumental coping. Front Psychol. 2021;12:674032. doi: 10.3389/fpsyg.2021.674032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Gruber J, Prinstein MJ, Clark LA, Rottenberg J, Abramowitz JS, Albano AM, et al. Mental health and clinical psychological science in the time of COVID-19: challenges, opportunities, and a call to action. Am Psychol. 2021;76(3):409–26. doi: 10.1037/amp0000707 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7(6):547–60. doi: 10.1016/S2215-0366(20)30168-1 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Wanli Zang

21 Jun 2026

-->PONE-D-26-19080-->-->Factors associated with fear and coping strategies during pandemic in female university students: The moderator role of physical activity and infection status-->-->PLOS One

Dear Dr. ERMİŞ,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 05 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Guest Editor

PLOS One

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. In the online submission form you indicate that your data is not available for proprietary reasons and have provided a contact point for accessing this data. Please note that your current contact point is a co-author on this manuscript. According to our Data Policy, the contact point must not be an author on the manuscript and must be an institutional contact, ideally not an individual. Please revise your data statement to a non-author institutional point of contact, such as a data access or ethics committee, and send this to us via return email. Please also include contact information for the third party organization, and please include the full citation of where the data can be found.

3. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: No

Reviewer #2: Partly

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: • It is recommended that the introduction conclude with a clear statement of the paper's purpose, a summary of its novel contributions, and a description of its position within the specialized scientific literature.

• The statistical software should be cited as follows: GraphPad Software. (2023). GraphPad Prism (Version 9) [Computer software]. San Diego, CA: GraphPad Software, Inc. Available at https://www.graphpad.com.

• The discussion section should begin by restating the study's purpose and explicitly indicating whether this objective was achieved.

• Additionally, a subchapter titled "Study strengths, limitations, future directions, and clinical implications" should be included, or these topics should be addressed in separate subsections within the discussion section.

Reviewer #2: Manuscript ID: PONE-D-26-19080

Manuscript Title: "Factors associated with fear and coping strategies during pandemic in female university students: The moderator role of physical activity and infection status"

1. Major Revisions & Methodological Concerns

a) Critical Contradiction in Sample Description

There is a fundamental contradiction between the text in the Participants and Procedure section and the data presented in Table 1:

- Text statement: "All participants included in the study were laboratory-confirmed. Our cohort reported being vaccinated before infection." This phrasing strongly implies that 100% of the sample contracted COVID-19.

--Table 1 data: Indicates that only 27.4% (N=274) were COVID-19 positive, while 72.6% (N=726) were COVID-19 negative.

- Reviewer Action Item: The authors must explicitly clarify what "laboratory-confirmed" refers to. If it means verified PCR status (regardless of whether positive or negative), the wording must be heavily revised to avoid misleading readers into thinking it was an entirely post-infection cohort.

b) Timeline Contextualization (2023 vs. Active Pandemic)

The data collection period is stated as July–December 2023. By late 2023, the World Health Organization (WHO) had declared an end to COVID-19 as a global health emergency, and daily public restrictions had largely abated.

- The manuscript regularly frames the study as capturing experiences "during the outbreak" or addressing an active crisis context.

- Reviewer Action Item: The authors need to contextualize their discussion. Are participants recalling past trauma, or are they reacting to the tail-end landscape of 2023? The use of the word "outbreak" should be adjusted to accurately match the late-2023 epidemiological landscape.

c) Convoluted Moderation Logic in Discussion

- The interpretation of the physical activity moderation results requires deeper nuance:The simple slope analysis reveals that the positive relationship between fear (FCV-19S) and coping (COS) is significantly steeper for sedentary individuals (slope = 0.79) than for recreationally active individuals (slope = 0.28).

- The authors argue that active individuals have better mental health frameworks, which "contributed to our cohort experiencing less fear... and thus producing fewer coping strategies.

- "Reviewer Action Item: This logic is counterintuitive. Active individuals might actually possess a baseline level of adaptive coping mechanisms that operate independently of high fear states, meaning their coping behaviors do not rely heavily on being afraid. Conversely, sedentary individuals may only deploy coping mechanisms when fear reaches acute thresholds. The authors should revise this portion of the discussion to improve clarity and avoid contradictory statements.

2. Minor Revisions & Data Reporting Adjustments

a) Typographical and Nomenclature Consistency

- Variable Names: In the text describing the PROCESS Macro results for MV1 and MV2, the authors refer to the dependent variable as "the COP variable". However, throughout the rest of the paper, the scale is abbreviated as COS (Coping with Outbreak Scale). This must be standardized to "COS" across the entire manuscript.

- Statistical Abbreviations: Ensure that standard symbols are formatted uniformly (e.g., matching the use of unstandardized regression coefficients $B$ versus standardized betas, or standardizing alpha levels across sections).

b) Clarification on "Relatives or Close Friends Who Died"

- Table 1 shows that 53.6% (N=536) of the participants reported having a relative or close friend who died from COVID-19. This is an extraordinarily high proportion for a single convenience sample.

- Reviewer Action Item: The authors should offer brief context regarding regional or local mortality impacts near the University of Ondokuz Mayıs during peak waves to ground this figure, as this variable likely represents a massive confounding psychological stressor that could cloud the specific impact of personal infection status (MV2).

3. Reviewer Conclusion & Recommendation

- Recommendation: Major Revision

- Summary Evaluation:This manuscript addresses an important demographic (young female university students) and evaluates useful protective behavioral variables (physical activity). The sample size (N=1000) provides excellent statistical power for the moderation models applied. However, the manuscript cannot be accepted in its current state due to the blatant text-to-table contradiction regarding participant infection status and the lack of historical/epidemiological anchoring for a study conducted in late 2023. Resolving these narrative and data alignment problems is essential prior to publication.

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?  For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: No

Reviewer #2: Yes: Dr Rimah Melati Ab Ghani

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Aug 11;21(8):e0355544. doi: 10.1371/journal.pone.0355544.r002

Author response to Decision Letter 1


23 Jun 2026

Point-by-point response addressing queries from the reviewer

Ref.: ONE-D-26-19080

Factors associated with fear and coping strategies during pandemic in female university students: The moderator role of physical activity and infection status

Reviewer 1

Thank you for reviewing our paper and providing constructive comments. We have done our best to address your queries in this version.

Comment #1:

It is recommended that the introduction conclude with a clear statement of the paper's purpose, a summary of its novel contributions, and a description of its position within the specialized scientific literature.

Response #1:

Thank you for this valuable suggestion. We have revised the final paragraph of the Introduction to more clearly state the study purpose, highlight its novel contributions, and position the study within the existing literature on fear and coping strategies (please see page 3, lines 70-81 in the marked version of the manuscript).

Comment #2:

The statistical software should be cited as follows: GraphPad Software. (2023). GraphPad Prism (Version 9) [Computer software]. San Diego, CA: GraphPad Software, Inc. Available at https://www.graphpad.com.

Response #2:

Thank you for the suggestion. The recommended citation for GraphPad Prism has been added to the statistical analysis section (please see page 7, lines 167-168 in the marked version of the manuscript).

Comment #3:

The discussion section should begin by restating the study's purpose and explicitly indicating whether this objective was achieved.

Response #3:

Thank you for this suggestion. The opening paragraph of the Discussion has been revised to clearly restate the study purpose (please see page 10, lines 212-215 in the marked version of the manuscript).

Comment #4:

Additionally, a subchapter titled "Study strengths, limitations, future directions, and clinical implications" should be included, or these topics should be addressed in separate subsections within the discussion section.

Response #4:

Thank you for this recommendation. We have reorganized the final section of the Discussion and added a dedicated subsection entitled “Study strengths, limitations, and future directions” to improve clarity and align with journal recommendations (please see pages 13-14, lines 297-321 in the marked version of the manuscript).

________________________________________________________________________________

Reviewer 2

Thank you for reviewing our paper and providing constructive comments. We have done our best to address your queries in this version.

Comment #1:

a) Critical Contradiction in Sample Description

There is a fundamental contradiction between the text in the Participants and Procedure section and the data presented in Table 1:

- Text statement: "All participants included in the study were laboratory-confirmed. Our cohort reported being vaccinated before infection." This phrasing strongly implies that 100% of the sample contracted COVID-19.

-Table 1 data: Indicates that only 27.4% (N=274) were COVID-19 positive, while 72.6% (N=726) were COVID-19 negative.

- Reviewer Action Item: The authors must explicitly clarify what "laboratory-confirmed" refers to. If it means verified PCR status (regardless of whether positive or negative), the wording must be heavily revised to avoid misleading readers into thinking it was an entirely post-infection cohort.

Response #1a:

Thank you for highlighting this ambiguity. We agree that the original wording could be misinterpreted as indicating that all participants had previously contracted COVID-19. Our intention was to specify that only participants classified as COVID-19 positive reported a laboratory-confirmed diagnosis. To improve clarity, we revised the manuscript to indicate that COVID-19 infection status was based on laboratory-confirmed diagnoses reported through the official Turkish Ministry of Health electronic health record system (e-Nabız), which is directly accessible to individuals (please see page 4, lines 95-98 in the marked version of the manuscript).

b) Timeline Contextualization (2023 vs. Active Pandemic)

The data collection period is stated as July–December 2023. By late 2023, the World Health Organization (WHO) had declared an end to COVID-19 as a global health emergency, and daily public restrictions had largely abated.

- The manuscript regularly frames the study as capturing experiences "during the outbreak" or addressing an active crisis context.

- Reviewer Action Item: The authors need to contextualize their discussion. Are participants recalling past trauma, or are they reacting to the tail-end landscape of 2023? The use of the word "outbreak" should be adjusted to accurately match the late-2023 epidemiological landscape.

Response #1b:

Thank you for this important observation. We agree that the original wording may not have adequately reflected the epidemiological context in which the data were collected. Although the acute phase of the pandemic had largely subsided by late 2023, COVID-19-related concerns, previous infection experiences, and associated psychological responses remained present among university students. Therefore, the present study reflects participants’ contemporaneous perceptions and coping responses during the post-emergency phase of the COVID-19 pandemic. To clarify this point, we revised the title, Abstract, Introduction, Participants and Procedure, Measures, Discussion, and Conclusion sections. We also replaced or qualified terms such as “during the outbreak” and “during the pandemic” with wording that more accurately reflects the post-emergency phase of COVID-19. Furthermore, we have added a detail to the ‘Methods’ section stating that the responses relate to the current situation regarding COVID-19 (please see page 5, lines 123-124 in the marked version of the manuscript).

c) Convoluted Moderation Logic in Discussion

- The interpretation of the physical activity moderation results requires deeper nuance: The simple slope analysis reveals that the positive relationship between fear (FCV-19S) and coping (COS) is significantly steeper for sedentary individuals (slope = 0.79) than for recreationally active individuals (slope = 0.28).

- The authors argue that active individuals have better mental health frameworks, which "contributed to our cohort experiencing less fear... and thus producing fewer coping strategies.

- "Reviewer Action Item: This logic is counterintuitive. Active individuals might actually possess a baseline level of adaptive coping mechanisms that operate independently of high fear states, meaning their coping behaviors do not rely heavily on being afraid. Conversely, sedentary individuals may only deploy coping mechanisms when fear reaches acute thresholds. The authors should revise this portion of the discussion to improve clarity and avoid contradictory statements.

Response #1c:

Thank you for this insightful comment. We have revised the Discussion to avoid implying that recreationally active individuals simply experienced less fear and therefore used fewer coping strategies. Instead, we now interpret the flatter slope among recreationally active individuals as suggesting that their coping responses may be less dependent on elevated fear levels, potentially reflecting more stable or pre-existing adaptive coping resources. Conversely, the steeper slope among sedentary individuals may indicate that coping responses become more strongly activated as fear increases (please see page 12, lines 259-271 in the marked version of the manuscript).

Comment #2:

a) Typographical and Nomenclature Consistency

- Variable Names: In the text describing the PROCESS Macro results for MV1 and MV2, the authors refer to the dependent variable as "the COP variable". However, throughout the rest of the paper, the scale is abbreviated as COS (Coping with Outbreak Scale). This must be standardized to "COS" across the entire manuscript.

- Statistical Abbreviations: Ensure that standard symbols are formatted uniformly (e.g., matching the use of unstandardized regression coefficients $B$ versus standardized betas, or standardizing alpha levels across sections).

Response #2a:

Thank you for identifying this inconsistency. We have corrected all references to ‘‘COP’’ and replaced them with the appropriate abbreviation, ‘‘COS,’’ throughout the manuscript to ensure consistency. In addition, we reviewed the reporting of statistical notation and harmonized the presentation of statistical symbols, regression coefficients (B), and significance levels across the text, tables, and figure legends (please see page 9, lines 184-206 in the marked version of the manuscript).

b) Clarification on "Relatives or Close Friends Who Died"

- Table 1 shows that 53.6% (N=536) of the participants reported having a relative or close friend who died from COVID-19. This is an extraordinarily high proportion for a single convenience sample.

- Reviewer Action Item: The authors should offer brief context regarding regional or local mortality impacts near the University of Ondokuz Mayıs during peak waves to ground this figure, as this variable likely represents a massive confounding psychological stressor that could cloud the specific impact of personal infection status (MV2).

Response #2b:

Thank you for this observation. We agree that the proportion of participants reporting the loss of a relative or close friend due to COVID-19 appears substantial. However, the survey item combined both relatives and close friends, thereby capturing losses occurring within a broader social network rather than only within the immediate family. Given the widespread impact of COVID-19 across Türkiye during the pandemic years, such experiences were relatively common among young adults. To provide additional context and avoid overinterpretation, we have clarified this point in the manuscript and acknowledged that bereavement-related experiences may have contributed to participants’ psychological responses during the study period (please see page 13, lines 292-296 in the marked version of the manuscript).

Comment #3:

- Summary Evaluation: This manuscript addresses an important demographic (young female university students) and evaluates useful protective behavioral variables (physical activity). The sample size (N=1000) provides excellent statistical power for the moderation models applied. However, the manuscript cannot be accepted in its current state due to the blatant text-to-table contradiction regarding participant infection status and the lack of historical/epidemiological anchoring for a study conducted in late 2023. Resolving these narrative and data alignment problems is essential prior to publication.

Response #3:

Thank you for your constructive assessment of our manuscript. In response to these concerns, we thoroughly revised the manuscript to resolve the inconsistency regarding participant infection status and to better contextualize the study within the late-2023 post-emergency phase of COVID-19. We believe that these revisions have substantially improved the clarity, consistency, and interpretability of the manuscript.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0355544.s002.docx (39.9KB, docx)

Decision Letter 1

Wanli Zang

17 Jul 2026

-->PONE-D-26-19080R1-->-->Factors associated with fear and coping strategies during pandemic in female university students: The moderator role of physical activity and infection status-->-->PLOS One

Dear Dr. ERMİŞ,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 31 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

-->

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Wanli Zang, Ph.D.

Guest Editor

PLOS One

Journal Requirements:

1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

-->2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: • It is recommended that the introduction conclude with a clear statement of the paper's purpose, a summary of its novel contributions, and a description of its position within the specialized scientific literature.

• The statistical software should be cited as follows: GraphPad Software. (2023). GraphPad Prism (Version 9) [Computer software]. San Diego, CA: GraphPad Software, Inc. Available at https://www.graphpad.com.

• The discussion section should begin by restating the study's purpose and explicitly indicating whether this objective was achieved.

• Additionally, a subchapter titled "Study strengths, limitations, future directions, and clinical implications" should be included, or these topics should be addressed in separate subsections within the discussion section.

Reviewer #2: Manuscript ID: PONE-D-26-19080R1

Title: "Factors associated with fear and coping strategies during pandemic in female university students: The moderator role of physical activity and infection status"

General Evaluation

The authors have done an excellent job addressing the primary concerns from the first round of reviews. The clarity of the methodology, the accuracy of the baseline descriptive data representation, and the contextual framing of the timeline have all significantly improved. By switching the focus to the post-emergency phase (reflecting the July–December 2023 data collection timeline) and depositing the de-identified raw dataset as a Supporting Information file, the manuscript now complies with PLOS ONE's rigorous publication standards.

1. Major Comments and Revisions Addressed

1.1 Resolution of Sample Contradiction

1.1.1 Previous Concern: The initial draft erroneously implied that 100% of the cohort had experienced a COVID-19 infection, clashing directly with Table 1 (27.4% positive).

1.1.2 Revision Assessment: The authors clarified the text to specify that among those classified as positive, status was cross-checked with the official Turkish electronic health record system (e-Nabız). This fully resolves the previous ambiguity.

1.2 Timeline and Post-Emergency Contextualization

1.2.1 Previous Concern: The framework failed to acknowledge that data was collected in late 2023, long after the height of the acute crisis phase.

1.2.2 Revision Assessment: The text now accurately frames the study within the "post-emergency phase," adapting both the Introduction and Discussion sections to reflect long-term or residual health anxiety rather than immediate crisis behaviors.

1.3 Correction of Moderation Logic

1.3.1 Previous Concern: The explanation regarding simple slopes for recreationally active versus sedentary individuals was counterintuitive.

1.3.2 Revision Assessment: The updated Discussion provides a statistically sound interpretation. It notes that sedentary individuals' coping dynamics are highly contingent upon fear thresholds, whereas active individuals show a more stable, baseline repertoire of coping mechanisms that remain resilient irrespective of high fear.

2. Minor Observations for Final Polish

2.1 Typographical Consistency: In the Data Analysis section, the authors successfully standardized references to the dependent variable scale as COS (Coping with Outbreak Scale), eliminating the accidental "COP" shorthand found in the previous draft.

2.2Confounding Acknowledgment: The new paragraph in the Discussion section properly addresses the high bereavement rate (53.6%) among participants as a potential source of unmeasured psychological variance, providing necessary context for this uniquely high descriptive metric.

3. Recommendation

Recommendation: Accept with No Further Revisions (or minor formatting polish at the editorial level).

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?  For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: No

Reviewer #2: Yes: Dr Rimah Melati Ab Ghani

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

-->

PLoS One. 2026 Aug 11;21(8):e0355544. doi: 10.1371/journal.pone.0355544.r004

Author response to Decision Letter 2


21 Jul 2026

We sincerely thank Reviewers 1 and 2 for their careful re-evaluation of our revised manuscript and for their positive feedback. We greatly appreciate their recognition of the revisions made in response to the initial comments. Their constructive suggestions have significantly improved the quality and clarity of our manuscript, and we are grateful for the time and effort they devoted to the review process.

Attachment

Submitted filename: Response_to_Reviewers_auresp_2.docx

pone.0355544.s003.docx (39.9KB, docx)

Decision Letter 2

Wanli Zang

23 Jul 2026

Factors associated with fear and coping strategies during pandemic in female university students: The moderator role of physical activity and infection status

PONE-D-26-19080R2

Dear Dr. ERMİŞ,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Wanli Zang, Ph.D.

Guest Editor

PLOS One

Additional Editor Comments (optional):

The revised manuscript has adequately addressed the previous comments. Its overall quality has been substantially improved and now meets the journal’s publication standards. I recommend acceptance in its present form.

Reviewers' comments:

Acceptance letter

Wanli Zang

PONE-D-26-19080R2

PLOS One

Dear Dr. ERMİŞ,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Wanli Zang

Guest Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0355544.s002.docx (39.9KB, docx)
    Attachment

    Submitted filename: Response_to_Reviewers_auresp_2.docx

    pone.0355544.s003.docx (39.9KB, docx)

    Data Availability Statement

    De-identified participant-level data underlying the findings are provided as Supporting information (S1 Dataset; Excel format). Summary data are included in the manuscript. The dataset has been anonymized to protect participant privacy.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES